Loading viewer...
investor_presentation
Format: PDF investor_presentation
Tivity Health Q3 2019 Earnings Release Supplemental Material November 12, 2019
Q3 2019 Earnings Release
Supplemental Material
© 2019 Tivity Health, Inc. All rights reserved.Note on Forward- Looking Statements
This communication contains certain statements that are “forward -looking” statements within the meaning of the federal securitie s laws, including Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward -looking st atements are based upon current
expectations and include all statements that are not historical statements of fact and those regarding the intent, belief or expectations, including, without limitation,
statements that are accompanied by words such as “will,” “expect,” “outlook,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” or other
similar words, phrases or expressions and variations or negatives of these words. These forward -looking statements include, but are not limited to, statements regarding
Tivity Health, Inc.’s (the “Company”) future financial performance and the Company’s acquisition of Nutrisystem, Inc. (“Nutrisystem ”), as well as the expected benefits,
synergies or opportunities of such acquisition. Readers of this communication should understand that these statements are not guarantees of performance or results. Many
risks and uncertainties could affect actual results and cause them to vary materially from the expectations contained in the for ward -looking statements.
These risks and uncertainties include, among other things: the market’s acceptance of the Company’s new products and services ; the Company’s ability to develop and
implement effective strategies and to anticipate and respond to strategic changes, opportunities, and emerging trends in the Com pany’s industry and/or business, as well as
to accurately forecast the related impact on the Company’s revenues and earnings; the risk that expected benefits, synergies and growth opportunities of the Company’s
acquisition of Nutrisystem may not be achieved in a timely manner or at all, including that the acquisition may not be accret ivewithin the expected timeframe or to the
extent anticipated; the Company’s ability to successfully integrate Nutrisystem's business or any other new or acquired businesses, services, technologies, solutions, or
products into the Company’s business and to accurately forecast the related costs; the risk that the significant indebtedness incurred in connection with the Company’s
acquisition of Nutrisystem may limit the Company’s ability to adapt to changes in the economy or market conditions, expose the C ompany to interest rate risk for the
variable rate indebtedness and require a substantial portion of cash flows from operations to be dedicated to the payment of indebtedness; the Company’s ability to service its debt, make principal and interest payments as those payments become due, and remain in compliance with its debt covenants ; the Company’s ability to obtain adequate
Preview truncated — download the full document for the complete content.
presentation
investor_presentation
29 Pages
Tryp Therapeutics Inc.